4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-005936
Chief Executive Officer sold 19,300 shares at an average $35.26 ($680,534)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-01-25 | Sale | −1,400 | $33.22 | $46,508 | 309,578 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-01-25 | Sale | −8,400 | $34.23 | $287,532 | 301,178 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-01-25 | Sale | −200 | $34.68 | $6,936 | 300,978 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-01-26 | Sale | −1,100 | $35.46 | $39,006 | 299,878 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-01-26 | Sale | −6,100 | $36.54 | $222,894 | 293,778 | I |
| Ciechanover Isaac E. Chief Executive Officer | 2018-01-26 | Sale | −2,100 | $36.98 | $77,658 | 291,678 | I |
| Open-market sales · 19,300 sh · avg $35.26 · $680,534 | |||||||
Loading xslF345X03/doc4.xml…